Sumatriptan Succinate Tablet
Product Images NDC 76420-093

4 FDA label images from Asclemed Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 76420-093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Figure1)

Image Description (Figure1)
A line graph showing the estimated probability of response over time in minutes from initial dose for different doses of Sumatriptan Succinate tablets (25 mg, 50 mg, 100 mg) compared to placebo. The y-axis represents the estimated probability of response (0%-100%), and the x-axis represents time in minutes (0-240). The higher doses show greater probability of response over time than placebo.*
FDA Label Image

Image Description (Figure2)

Image Description (Figure2)
A line graph showing the estimated probability of remediation or rescue over time (up to 24 hours) from the initial dose, comparing placebo and three doses of Sumatriptan Succinate tablets: 25 mg, 50 mg, and 100 mg. The y-axis represents probability percentage, and the x-axis represents time in hours.*
FDA Label Image

Image Description (Label)

Image Description (Label)
Sumatriptan Tablets, USP 50 mg oral tablet label showing a quantity of 9 tablets. The label includes the NDC 76420-093-09, and indicates the manufacturer as Dr. Reddy's Laboratories Limited with a source NDC of 55111-292-09. The label is relabeled by Enovachem Pharmaceuticals, Torrance, CA, and includes barcode and regulatory caution statements.*
FDA Label Image

Image Description (Structure)

Image Description (Structure)
Chemical structure of sumatriptan succinate showing its indole ring with attached sulfonamide and dimethylaminoethyl side chains, and the succinate portion with carboxylic acid groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.